T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Schlumberger
SLB
|
+$2.5B |
| 2 |
Kenvue
KVUE
|
+$1.3B |
| 3 |
Halliburton
HAL
|
+$1.16B |
| 4 |
Charles Schwab
SCHW
|
+$836M |
| 5 |
Boeing
BA
|
+$832M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$2.52B |
| 2 |
Apple
AAPL
|
+$1.77B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.57B |
| 4 |
Johnson & Johnson
JNJ
|
+$1.47B |
| 5 |
Intuit
INTU
|
+$1.14B |
Sector Composition
| 1 | Technology | 29.85% |
| 2 | Healthcare | 16.84% |
| 3 | Financials | 10.89% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
851
Amphastar Pharmaceuticals
AMPH
$1.32B
| $26.2M | ﹤0.01% |
569,712
+63,404
| +13% | +$2.92M |
|
|
GTM
852
ZoomInfo Technologies
GTM
$3.63B
| $26.1M | ﹤0.01% |
1,590,566
-705,543
| -31% | -$11.6M |
|
853
Royal Gold
RGLD
$12.3B
| $25.9M | ﹤0.01% |
243,129
-97,150
| -29% | -$10.3M |
|
854
SL Green Realty
SLG
$4.29B
| $25.8M | ﹤0.01% |
691,780
+148,380
| +27% | +$5.53M |
|
855
EPAM Systems
EPAM
$8.53B
| $25.8M | ﹤0.01% |
100,872
-151,589
| -60% | -$38.8M |
|
856
Penske Automotive Group
PAG
$12.2B
| $25.8M | ﹤0.01% |
154,306
+15,009
| +11% | +$2.51M |
|
857
Payoneer
PAYO
$2.33B
| $25.8M | ﹤0.01% |
4,207,321
+3,518,714
| +511% | +$21.5M |
|
858
NCR Voyix
VYX
$1.73B
| $25.7M | ﹤0.01% |
1,555,946
+148,563
| +11% | +$2.46M |
|
859
AXIS Capital
AXS
$7.59B
| $25.7M | ﹤0.01% |
455,293
+15,892
| +4% | +$896K |
|
860
Exponent
EXPO
$3.5B
| $25.6M | ﹤0.01% |
298,647
-325,117
| -52% | -$27.8M |
|
861
Blackbaud
BLKB
$3.33B
| $25.5M | ﹤0.01% |
362,838
+12,429
| +4% | +$874K |
|
862
Informatica
INFA
$7.55B
| $25M | ﹤0.01% |
1,187,850
-158,174
| -12% | -$3.33M |
|
863
SM Energy
SM
$3.14B
| $25M | ﹤0.01% |
630,307
-385,955
| -38% | -$15.3M |
|
864
Everest Group
EG
$14.3B
| $24.9M | ﹤0.01% |
67,002
+54
| +0.1% | +$20.1K |
|
865
Madrigal Pharmaceuticals
MDGL
$9.59B
| $24.9M | ﹤0.01% |
170,373
+114,970
| +208% | +$16.8M |
|
866
Northern Trust
NTRS
$24.2B
| $24.8M | ﹤0.01% |
357,525
-26,879
| -7% | -$1.87M |
|
867
Disc Medicine
IRON
$2.08B
| $24.8M | ﹤0.01% |
527,739
+325,069
| +160% | +$15.3M |
|
868
PTC Therapeutics
PTCT
$4.63B
| $24.7M | ﹤0.01% |
1,102,445
-974,489
| -47% | -$21.8M |
|
869
Extreme Networks
EXTR
$2.96B
| $24.6M | ﹤0.01% |
1,015,454
+123,446
| +14% | +$2.99M |
|
870
Suzano
SUZ
$11.7B
| $24.3M | ﹤0.01% |
2,257,819
+647,148
| +40% | +$6.96M |
|
|
PRFT
871
DELISTED
Perficient Inc
PRFT
| $24M | ﹤0.01% |
415,268
-19,536
| -4% | -$1.13M |
|
872
Invitation Homes
INVH
$18.4B
| $24M | ﹤0.01% |
757,045
-17,497
| -2% | -$555K |
|
873
Hudbay
HBM
$5.33B
| $24M | ﹤0.01% |
+4,920,429
| New | +$24M |
|
874
Pultegroup
PHM
$26.7B
| $23.9M | ﹤0.01% |
322,823
-6,397
| -2% | -$474K |
|
875
BHP
BHP
$135B
| $23.7M | ﹤0.01% |
416,098
+14,907
| +4% | +$848K |
|